Effects of Canagliflozin on MACE by Baseline eGFR
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effects of canagliflozin on major adverse cardiovascular events (MACE) by baseline estimated glomerular filtration rate: pooled Hispanic subgroup analyses from the CANVAS Program and CREDENCE trial
Diabetes Obes Metab 2021 Aug 31;[EPub Ahead of Print], MR Weir, J Gogate, CV Damaraju, R Correa-Rotter, KW MahaffeyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.